Investment Summary |
|
|---|---|
| Date | 2016-01-20 |
| Target | Kaleido |
| Sector | Medical Products |
| Investor(s) | EQT Life Sciences |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 47 |
| Sector: Medical Products M&A | 5 of 14 |
| Type: Venture M&A Deals | 6 of 39 |
| Country: Netherlands M&A | 5 of 10 |
| Year: 2016 M&A | 1 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-06-01 |
Kiadis Pharma
Amsterdam, Netherlands Kiadis Pharma is a clinical stage biopharmaceutical company pioneering a proprietary cell-based, personalized therapy for patients with blood cancers and related disorders, an area of significant unmet medical need.Kiadis Pharma’s unique and powerful platform technology has led to an initial experimental product, ATIR™, which has already been clinically tested on sixty patients. Kiadis Pharma is based in Amsterdam, Netherlands. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-03-14 |
eTheRNA
Niel, Belgium eTheRNA is developing its proprietary TriMix mRNA-based immunotherapies for melanoma, breast cancer and infectious diseases. eTheRNA was founded in 2013 and is based in Niel, Belgium. |
Buy | - |
